Global Intrauterine Contraceptive Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 149721
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Medical Devices

An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.

Scope of the Report:

Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.

The worldwide market for Intrauterine Contraceptive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Intrauterine Contraceptive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Teva Pharmaceutical Industries

Medicines360

Trimedic Supply Network

Bayer Healthcare

Actavis

Medisafe Distribution

Pace Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hormonal IUCD

Copper IUCD

Market Segment by Applications, can be divided into

Hospitals

Gynecological Clinics

Other

There are 15 Chapters to deeply display the global Intrauterine Contraceptive market.

Chapter 1, to describe Intrauterine Contraceptive Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intrauterine Contraceptive, with sales, revenue, and price of Intrauterine Contraceptive, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intrauterine Contraceptive, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intrauterine Contraceptive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intrauterine Contraceptive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Intrauterine Contraceptive Introduction

1.2 Market Analysis by Type

1.2.1 Hormonal IUCD

1.2.2 Copper IUCD

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Gynecological Clinics

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Teva Pharmaceutical Industries

2.1.1 Business Overview

2.1.2 Intrauterine Contraceptive Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Teva Pharmaceutical Industries Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Medicines360

2.2.1 Business Overview

2.2.2 Intrauterine Contraceptive Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Medicines360 Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Trimedic Supply Network

2.3.1 Business Overview

2.3.2 Intrauterine Contraceptive Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Trimedic Supply Network Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bayer Healthcare

2.4.1 Business Overview

2.4.2 Intrauterine Contraceptive Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bayer Healthcare Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Actavis

2.5.1 Business Overview

2.5.2 Intrauterine Contraceptive Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Actavis Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Medisafe Distribution

2.6.1 Business Overview

2.6.2 Intrauterine Contraceptive Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Medisafe Distribution Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pace Pharmaceuticals

2.7.1 Business Overview

2.7.2 Intrauterine Contraceptive Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pace Pharmaceuticals Intrauterine Contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Intrauterine Contraceptive Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Intrauterine Contraceptive Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Intrauterine Contraceptive Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Intrauterine Contraceptive Manufacturer Market Share in 2017

3.3.2 Top 6 Intrauterine Contraceptive Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Intrauterine Contraceptive Market Analysis by Regions

4.1 Global Intrauterine Contraceptive Sales, Revenue and Market Share by Regions

4.1.1 Global Intrauterine Contraceptive Sales and Market Share by Regions (2013-2018)

4.1.2 Global Intrauterine Contraceptive Revenue and Market Share by Regions (2013-2018)

4.2 North America Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

4.3 Europe Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

4.5 South America Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

5 North America Intrauterine Contraceptive by Countries

5.1 North America Intrauterine Contraceptive Sales, Revenue and Market Share by Countries

5.1.1 North America Intrauterine Contraceptive Sales and Market Share by Countries (2013-2018)

5.1.2 North America Intrauterine Contraceptive Revenue and Market Share by Countries (2013-2018)

5.2 United States Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

5.3 Canada Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

5.4 Mexico Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

6 Europe Intrauterine Contraceptive by Countries

6.1 Europe Intrauterine Contraceptive Sales, Revenue and Market Share by Countries

6.1.1 Europe Intrauterine Contraceptive Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Intrauterine Contraceptive Revenue and Market Share by Countries (2013-2018)

6.2 Germany Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

6.3 UK Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

6.4 France Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

6.5 Russia Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

6.6 Italy Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

7 Asia-Pacific Intrauterine Contraceptive by Countries

7.1 Asia-Pacific Intrauterine Contraceptive Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Intrauterine Contraceptive Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Intrauterine Contraceptive Revenue and Market Share by Countries (2013-2018)

7.2 China Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

7.3 Japan Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

7.4 Korea Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

7.5 India Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

8 South America Intrauterine Contraceptive by Countries

8.1 South America Intrauterine Contraceptive Sales, Revenue and Market Share by Countries

8.1.1 South America Intrauterine Contraceptive Sales and Market Share by Countries (2013-2018)

8.1.2 South America Intrauterine Contraceptive Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

8.3 Argentina Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

8.4 Colombia Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

9 Middle East and Africa Intrauterine Contraceptive by Countries

9.1 Middle East and Africa Intrauterine Contraceptive Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Intrauterine Contraceptive Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Intrauterine Contraceptive Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

9.3 UAE Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

9.4 Egypt Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

9.5 Nigeria Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

9.6 South Africa Intrauterine Contraceptive Sales and Growth Rate (2013-2018)

10 Global Intrauterine Contraceptive Market Segment by Type

10.1 Global Intrauterine Contraceptive Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Intrauterine Contraceptive Sales and Market Share by Type (2013-2018)

10.1.2 Global Intrauterine Contraceptive Revenue and Market Share by Type (2013-2018)

10.2 Hormonal IUCD Sales Growth and Price

10.2.1 Global Hormonal IUCD Sales Growth (2013-2018)

10.2.2 Global Hormonal IUCD Price (2013-2018)

10.3 Copper IUCD Sales Growth and Price

10.3.1 Global Copper IUCD Sales Growth (2013-2018)

10.3.2 Global Copper IUCD Price (2013-2018)

11 Global Intrauterine Contraceptive Market Segment by Application

11.1 Global Intrauterine Contraceptive Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Gynecological Clinics Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Intrauterine Contraceptive Market Forecast (2018-2023)

12.1 Global Intrauterine Contraceptive Sales, Revenue and Growth Rate (2018-2023)

12.2 Intrauterine Contraceptive Market Forecast by Regions (2018-2023)

12.2.1 North America Intrauterine Contraceptive Market Forecast (2018-2023)

12.2.2 Europe Intrauterine Contraceptive Market Forecast (2018-2023)

12.2.3 Asia-Pacific Intrauterine Contraceptive Market Forecast (2018-2023)

12.2.4 South America Intrauterine Contraceptive Market Forecast (2018-2023)

12.2.5 Middle East and Africa Intrauterine Contraceptive Market Forecast (2018-2023)

12.3 Intrauterine Contraceptive Market Forecast by Type (2018-2023)

12.3.1 Global Intrauterine Contraceptive Sales Forecast by Type (2018-2023)

12.3.2 Global Intrauterine Contraceptive Market Share Forecast by Type (2018-2023)

12.4 Intrauterine Contraceptive Market Forecast by Application (2018-2023)

12.4.1 Global Intrauterine Contraceptive Sales Forecast by Application (2018-2023)

12.4.2 Global Intrauterine Contraceptive Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Intrauterine Contraceptive Picture

Table Product Specifications of Intrauterine Contraceptive

Figure Global Sales Market Share of Intrauterine Contraceptive by Types

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery